Complications of Intralesional Bleomycin in the Treatment of Orbital Lymphatic Malformations

References

• Balakrishnan A, Bailey CM. Lymphangioma of the tongue: A review of pathogenesis, treatment and the use of surface laser photocoagulation. J Laryngol Otol 1991;105:924–930
   PubMed Web of Science ®Google Scholar
• Batasakis GJ, Rice HD. The pathology of head and neck tumours: Vasoformative tumours, Part 9a. Head Neck Surg 1981;3:231–239
   PubMedGoogle Scholar
• Brock ME, Smith RJH, Parey SE, Mobley DL. Lymphangioma: An otolayngologic perspective. Int J Pediatr Otorhi 1987;14:133–140
   PubMed Web of Science ®Google Scholar
• Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions. Ophthalmology 2004;111:997–1008
   PubMed Web of Science ®Google Scholar
• Wiegand S, Eivazi B, Bloch LM, et al. Lymphatic malformations of the orbit. Clin Exp Otorhinolaryngol 2013;6(1):30–35
   PubMed Web of Science ®Google Scholar
• Andreoli TE, Carpenter CCJ, Griggs RC, Loscalzo J. CECIL Essentials of Medicine, 6th ed., pp. 466–467; Philadelphia: Saunders, 2004
   Google Scholar
• Brouillard P, Vikkula M. Vascular malformations: Localized defects in vascular morphogenesis. Clin Genet 2003;63:340–351
   PubMed Web of Science ®Google Scholar
• Huang H-Y, Ho C-C, Huang P-H, Hsu S-M. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma: Implication in autocrine or paracrine regulation of lymphangioma. Lab Invest 2001;81:1729–1734
   PubMed Web of Science ®Google Scholar
• Yadav P, De Castro DK, Waner M, et al. Vascular anomalies of the head and neck: A review of genetics. Sem Ophthalmol 2013;28(5–6):257–266
   PubMed Web of Science ®Google Scholar
• Castro EC, Galambos C. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations: A proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009;12:187–194
   Google Scholar
• Hamoir M, Plouin-Guadon P, Rombaux P, et al. Lymphatic malformations of the head and neck: A retrospective review and a support for staging. Head Neck 2001;23:326–337
   PubMed Web of Science ®Google Scholar
• Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412–422
   PubMed Web of Science ®Google Scholar
• Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982;70:120–121
   PubMed Web of Science ®Google Scholar
• Kim DW. OK-432 sclerotherapy of lymphatic malformation in the head and neck: Factors related to outcome. Pediatr Radiol 2014;44(7):857--862
   Google Scholar
• Khan SN, Sepahdari AR. Orbital masses CT and MRI of common vascular lesions, benign tumros and malignancies. Saudi J Ophthalmol 2012;26:373–383
   PubMedGoogle Scholar
• Bilankuk, LT. Orbital vascular lesions: Role of imaging. Radiol Clin North America 1999;31(1):169–183
   Google Scholar
• Umezawa H. Recent studies on biochemistry and action of bleomycin. In: S.K. Carter, S.T. Crook, H. Umezawa (eds.) Bleomycin: Current Status and New Developments, pp. 15–20; New York: Academic, 1978
   Google Scholar
• Blum RH, Carter SK, Agre K. A clinical review of bleomycin: A new antineoplastic agent. Cancer 1973;31:903–914
   PubMed Web of Science ®Google Scholar
• Yura J, Hashimoto T, Tsuruga N, Shibata K. Belomycin treatment for cystic hygroma in children. Arch Jap Chir 1977;46(5):607–614
   PubMedGoogle Scholar
• Tanigawa N, Shimomatsuya T, Takahashi K, et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer 1987;60:741–749
   PubMed Web of Science ®Google Scholar
• Muir T, Kiersten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004;19:766–773
   PubMed Web of Science ®Google Scholar
• Tanaka K. Sclerosing therapy with bleomycin emulsion for lymphangioma in children. Ped Surg Int 1990;5:270–273
   Web of Science ®Google Scholar
• Orford J. Bleomycin therapy for cystic hygroma. J Ped Surg 1995;30(9):1282–1287
   PubMed Web of Science ®Google Scholar
• Zhong PQ, Zhi FX, Li R, et al. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86(2):139–144
   PubMed Web of Science ®Google Scholar
• Okada A, Kubota A, Fukuzawa M, et al. Injection of bleomycin as a primary therapy of cystic lymphangioma. J Pediatr Surg 1992;27(4):440–443
   PubMed Web of Science ®Google Scholar
• Sung M-W, Chang SO, Choi JH, Kim JY. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995;16(4):236–241
   PubMed Web of Science ®Google Scholar
• McGill TJ, Mulliken JB. Vascular anomalies of the head and neck. In: CW Cummings, JM Freidrickson, L.A. Harker, et al. (eds.), Otolaryngology: Head and Neck Surgery, 2nd ed., vol. 1, pp. 333–346; St. Louis: Mosby, 1993
   Google Scholar
• Shen CY, Wu CM, Tyan YS, Ou CH, Chen TY, Wong HF. Prelimary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery. Clin Radiol 2012;67:182–184
   PubMed Web of Science ®Google Scholar
• Dubois J, Garel L, Abela A, et al. Lymphangiomas in children: Percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997;204:651–654
   PubMed Web of Science ®Google Scholar
• Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, He F, Lin M, Ge S, Fan X. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: Evaluation of 33 consecutive patients. J Am Med Assoc 2014;132(8):942--948
   Google Scholar